BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

XOMA Inc.

About XOMA Inc.

XOMA develops biopharmaceuticals that target cancer, immunological disorders and infectious diseases.

 

LEAD PRODUCT --RAPTIVA -- control of chronic moderate-to-severe plaque psoriasis --APPROVED

 

PRODUCT PIPELINE

 

Neuprex - infectious and inflammatory conditions, congenital heart abnormalities

XMP.629 -- Acne

MLN2222 - Coronary artery bypass graft (CABG) surgery patients.

 

More on XOMA

Home page

Key Statistics for XOMA

Basic Chart for XOMA

Analyst Opinion

Analysts Estimates

 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com